Unveiling the mind's secrets without wearables
Dr. Nadeem Ahmed
Forbes 30u30 | DOH - Chairman's Office | Ex-McKinsey - Gen-AI use cases, Health Systems | Harvard Public Health Review - Managing Editor | Global 100 Leader - Oxford GLC, St. Gallen Symposium, Peter Drucker Forum
In 2019 alone, there were approximately 45.82 million new cases of anxiety disorders and 301.39 million existing cases worldwide, according to research by Xiaorong Yang et al. (2021). Affecting mainly those aged 16–65, mental disorders show varying prevalence across different regions. The economic impact is profound, with costs in 2010 estimated at $2.5 trillion. Mobio Interactive, co-founded in 2015 by Avetis Muradyan, Bechara Saab, and Mark Thoburn and headquartered in Singapore, is a key player in addressing these challenges through digital therapeutics in mental health.
Pain point addressed
The pain point addressed by Mobio Interactive is the difficulty in objectively quantifying mental health improvements and personalizing therapy, especially without the use of wearables. Their services are globally accessible, with significant implications in regions like the Asia-Pacific, offering value across the entire mental health treatment chain, from diagnosis to ongoing patient monitoring. The platform serves patients by providing personalized mental health interventions, healthcare providers through improved treatment monitoring, and insurers by potentially lowering long-term healthcare costs due to effective preventative care.
Type of solution
Mobio Interactive offers a digital solution for mental health management. Their platform, primarily software-based, leverages AI and advanced algorithms to monitor and treat mental health conditions, such as anxiety, without the need for additional hardware. This approach makes their solution highly scalable and accessible globally.
Type of input data leveraged
The type of input data leveraged by Mobio Interactive includes:
Key technology involved
The key technologies leveraged by Mobio Interactive include:
Key applications of solution
Implications of key stakeholders
Beyond just treatment, patients gain insights into their mental health status, enabling them to understand and manage their conditions better. For instance, a patient with chronic anxiety can monitor their stress levels in real-time, adjust their lifestyle, or seek timely intervention.
Clinicians receive a more nuanced view of their patients’ mental health, enabling precise treatment adjustments. A therapist could use data from the platform to tailor cognitive behavioral therapy sessions more effectively.
The technology promises more efficient treatment outcomes, potentially reducing long-term costs. Insurance companies could leverage this data to develop more accurate risk assessment models and tailor their health plans.
With objective, data-driven outcomes, regulatory agencies can better evaluate and approve mental health treatments, ensuring safer and more effective therapies for the public.
Current impact
领英推荐
Potential future impact
The potential future impact of Mobio Interactive’s digital therapeutic solutions is vast and multifaceted.
Business model
Mobio Interactive’s business model incorporates elements of B2B (Business-to-Business) and B2C (Business-to-Consumer) strategies. Key advantages of this model include:
Funding and key investors
Mobio Interactive’s funding journey showcases growing confidence from investors in their innovative approach to digital mental health solutions. They have successfully raised $2.4 million over four rounds of funding. The latest infusion of capital, acquired on August 16, 2023, from a grant round, signifies not just financial support but also a validation of their potential in the digital therapeutics market. This funding is crucial for the further development and expansion of their AI-driven mental health platforms, research initiatives, and global presence in the digital health sector. The key investors are: OPPO Inspiration Challenge, Creative ventures, SOSV, Atlas asset management, Verge healthtech fund, Chinaccelerator, Australian medical angels, and Orbit startups.
Competitive differentiator
Mobio Interactive’s competitive differentiator lies in its unique approach to mental health measurement:
Regulatory and compliance status
For a solution like Mobio Interactive’s, maintaining compliance with relevant regulatory and compliance requirements is crucial. These include:
Partnerships and collaborations
Mobio Interactive collaborates with health systems to introduce AmDTx to patients and employees, aiming to enhance mental health and human performance. These partnerships enable physicians to tailor therapy for their patients, with AmDTx offering rapid deployment in healthcare settings. This is particularly vital given the long wait times for mental health services globally. AmDTx adjusts to individual patient needs and provides objective well-being insights between healthcare visits, which physicians can utilize for informed treatment decisions.
Testimonials
“I can accept negative thoughts better than before and I can practice meditation to calm me down if the day was really stressful. I found that when I practice meditation before I sleep, I can sleep better than before, and I don’t wake up randomly in the middle of the night.– User
“I learned to unwind and be more aware of my surroundings. After a stressful day, I looked forward to doing the meditation for at least 10 minutes and it helped me become stress-free and understanding of what is there around me.” – User
Areas for continuous improvement
References
Disclaimer: Please note that the opinions, content, and analysis in my posts are entirely my own and do not reflect the views of any current or past employers or institutional affiliations. These posts, based solely on publicly available information, are for informational purposes and should not be taken as professional advice. All insights and conclusions are my viewpoints and should not be considered representative of any organizations I am or have been associated with. This content is not endorsed by, nor does it represent the stance of any affiliated entity.
Leading AI Adoption for Clinical Trials and Healthcare
10 个月Great to see personalized digital therapeutics for managing conditions like anxiety. I do truly believe that AI, despite the cold / robotic connotations, can increase empathy across the board and support all conditions (especially mental health).